UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antidepressant effects of insulin in streptozotocin induced diabetic mice: Modulation of brain serotonin system

Physiology & behavior, 2014-04, Vol.129, p.73-78

2014

Volltextzugriff (PDF)

ATR inhibition enables complete tumour regression in ALK-driven NB mouse models

Nature communications, 2021-11, Vol.12 (1), p.6813-6813, Article 6813

2021

Volltextzugriff (PDF)

Effect of a novel 5-HT3 receptor antagonist 4i, in corticosterone-induced depression-like behavior and oxidative stress in mice

Steroids, 2015-04, Vol.96, p.95-102

2015

Volltextzugriff (PDF)

Ondansetron, a 5HT3 receptor antagonist reverses depression and anxiety-like behavior in streptozotocin-induced diabetic mice: Possible implication of serotonergic system

European journal of pharmacology, 2014-12, Vol.744, p.59-66

2014

Volltextzugriff (PDF)

Pioglitazone, a PPARγ agonist rescues depression associated with obesity using chronic unpredictable mild stress model in experimental mice

Neurobiology of stress, 2016-06, Vol.3 (C), p.114-121

2016

Volltextzugriff (PDF)

Knockout of STE20-type kinase TAOK3 does not attenuate diet-induced NAFLD development in mice

Molecular medicine (Cambridge, Mass.), 2023-10, Vol.29 (1), p.138-138, Article 138

2023

Volltextzugriff (PDF)

Lipid droplet-associated kinase STK25 regulates peroxisomal activity and metabolic stress response in steatotic liver[S]

Journal of lipid research, 2020-02, Vol.61 (2), p.178-191

2020

Volltextzugriff (PDF)

Insulin reverses anxiety-like behavior evoked by streptozotocin-induced diabetes in mice

Metabolic brain disease, 2014-09, Vol.29 (3), p.737-746

2014

Volltextzugriff (PDF)

Antidepressant-like effects of a novel 5-HT3 receptor antagonist 6z in acute and chronic murine models of depression

Acta pharmacologica Sinica, 2014-12, Vol.35 (12), p.1493-1503

2014

Volltextzugriff (PDF)

STE20‐Type Protein Kinase MST4 Controls NAFLD Progression by Regulating Lipid Droplet Dynamics and Metabolic Stress in Hepatocytes

Hepatology communications, 2021-07, Vol.5 (7), p.1183-1200

2021

Volltextzugriff (PDF)

Ondansetron attenuates co-morbid depression and anxiety associated with obesity by inhibiting the biochemical alterations and improving serotonergic neurotransmission

Pharmacology, biochemistry and behavior, 2015-09, Vol.136, p.107-116

2015

Volltextzugriff (PDF)

A novel animal model of metabolic syndrome with non-alcoholic fatty liver disease and skin inflammation

Pharmaceutical biology, 2015-08, Vol.53 (8), p.1110-1117

2015

Volltextzugriff (PDF)

Pharmacological evaluation of novel 5-HT 3 receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery

Journal of pharmacy & bioallied science, 2015-04, Vol.7 (2), p.103-108

2015

Volltextzugriff (PDF)

Ondansetron ameliorates depression associated with obesity in high-fat diet fed experimental mice: An investigation-based on the behavioral, biochemical, and molecular approach

Indian journal of pharmacology, 2017-07, Vol.49 (4), p.290-296

2017

Volltextzugriff (PDF)

Role of Hypothalamic-pituitary-adrenal-axis in Affective Disorders: Anti-depressant and Anxiolytic Activity of Partial 5-HT1A Agonist in Adrenalectomised Rats

Indian journal of psychological medicine, 2013-07, Vol.35 (3), p.290-298

2013

Volltextzugriff (PDF)

QCM-4, a 5-HT3 receptor antagonist ameliorates plasma HPA axis hyperactivity, leptin resistance and brain oxidative stress in depression and anxiety-like behavior in obese mice

Biochemical and biophysical research communications, 2015-01, Vol.456 (1), p.74-79

2015

Volltextzugriff (PDF)

5HT3 receptor antagonist (ondansetron) reverses depressive behavior evoked by chronic unpredictable stress in mice: Modulation of hypothalamic–pituitary–adrenocortical and brain serotonergic system

Pharmacology, biochemistry and behavior, 2014-09, Vol.124, p.129-136

2014

Volltextzugriff (PDF)

Insulin reverses anxiety-like behavior evoked by streptozotocin-induced diabetes in mice

Metabolic brain disease, 2014-09, Vol.29 (3), p.737-746

2014

Volltextzugriff (PDF)

Mechanisms linking depression co-morbid with obesity: An approach for serotonergic type 3 receptor antagonist as novel therapeutic intervention

Asian journal of psychiatry, 2015-10, Vol.17, p.3-9

2015

Volltextzugriff (PDF)

Novel 5-HT^sub 3^ receptor antagonist QCM-4 attenuates depressive-like phenotype associated with obesity in high-fat-diet-fed mice

Psychopharmacology, 2017-04, Vol.234 (7), p.1165

2017

Volltextzugriff (PDF)

Novel 5-HT sub(3) receptor antagonist QCM-4 attenuates depressive-like phenotype associated with obesity in high-fat-diet-fed mice

Psychopharmacology, 2017-04, Vol.234 (7), p.1165-1179

2017

Volltextzugriff (PDF)

Novel 5-HT.sub.3 receptor antagonist QCM-4 attenuates depressive-like phenotype associated with obesity in high-fat-diet-fed mice

Psychopharmacology, 2017-04, Vol.234 (7), p.1165

2017

Volltextzugriff (PDF)

Novel 5-HT3 receptor antagonist QCM-4 attenuates depressive-like phenotype associated with obesity in high-fat-diet-fed mice

Psychopharmacology, 2017-04, Vol.234 (7), p.1165-1179

2017

Volltextzugriff (PDF)

Anxiolytic-like effects of alverine citrate in experimental mouse models of anxiety

European journal of pharmacology, 2014-11, Vol.742, p.94-101

2014

Volltextzugriff (PDF)

Effect of a Selective Cyclooxygenase Type 2 Inhibitor Celecoxib on Depression Associated with Obesity in Mice: An Approach Using Behavioral Tests

Neurochemical research, 2014-07, Vol.39 (7), p.1395-1402

2014

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(47)

Sprache

Englisch
(47)

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(27)
Animals
(24)
Mice
(21)
Male
(19)
Depression
(16)
Behavior, Animal - Drug Effects
(14)
Pharmacology & Pharmacy
(13)
Depression - Drug Therapy
(12)
Motor Activity - Drug Effects
(12)
Antidepressive Agents - Pharmacology
(11)
Anxiety
(11)
Obesity
(10)
Serotonin 5-Ht3 Receptor Antagonists - Pharmacology
(10)
Serotonin
(9)
Anxiety - Drug Therapy
(8)
Brain - Drug Effects
(8)
Brain - Metabolism
(8)
Oxidative Stress
(8)
Quinoxalines - Pharmacology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antidepressant effects of insulin in streptozotocin induced diabetic mice: Modulation of brain serotonin system

ATR inhibition enables complete tumour regression in ALK-driven NB mouse models

Effect of a novel 5-HT3 receptor antagonist 4i, in corticosterone-induced depression-like behavior and oxidative stress in mice

Ondansetron, a 5HT3 receptor antagonist reverses depression and anxiety-like behavior in streptozotocin-induced diabetic mice: Possible implication of serotonergic system

Pioglitazone, a PPARγ agonist rescues depression associated with obesity using chronic unpredictable mild stress model in experimental mice

Knockout of STE20-type kinase TAOK3 does not attenuate diet-induced NAFLD development in mice

Lipid droplet-associated kinase STK25 regulates peroxisomal activity and metabolic stress response in steatotic liver[S]

Insulin reverses anxiety-like behavior evoked by streptozotocin-induced diabetes in mice

Antidepressant-like effects of a novel 5-HT3 receptor antagonist 6z in acute and chronic murine models of depression

STE20‐Type Protein Kinase MST4 Controls NAFLD Progression by Regulating Lipid Droplet Dynamics and Metabolic Stress in Hepatocytes

Ondansetron attenuates co-morbid depression and anxiety associated with obesity by inhibiting the biochemical alterations and improving serotonergic neurotransmission

A novel animal model of metabolic syndrome with non-alcoholic fatty liver disease and skin inflammation

Pharmacological evaluation of novel 5-HT 3 receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery

Ondansetron ameliorates depression associated with obesity in high-fat diet fed experimental mice: An investigation-based on the behavioral, biochemical, and molecular approach

Role of Hypothalamic-pituitary-adrenal-axis in Affective Disorders: Anti-depressant and Anxiolytic Activity of Partial 5-HT1A Agonist in Adrenalectomised Rats

QCM-4, a 5-HT3 receptor antagonist ameliorates plasma HPA axis hyperactivity, leptin resistance and brain oxidative stress in depression and anxiety-like behavior in obese mice

5HT3 receptor antagonist (ondansetron) reverses depressive behavior evoked by chronic unpredictable stress in mice: Modulation of hypothalamic–pituitary–adrenocortical and brain serotonergic system

Insulin reverses anxiety-like behavior evoked by streptozotocin-induced diabetes in mice

Mechanisms linking depression co-morbid with obesity: An approach for serotonergic type 3 receptor antagonist as novel therapeutic intervention

Novel 5-HT^sub 3^ receptor antagonist QCM-4 attenuates depressive-like phenotype associated with obesity in high-fat-diet-fed mice

Novel 5-HT sub(3) receptor antagonist QCM-4 attenuates depressive-like phenotype associated with obesity in high-fat-diet-fed mice

Novel 5-HT.sub.3 receptor antagonist QCM-4 attenuates depressive-like phenotype associated with obesity in high-fat-diet-fed mice

Novel 5-HT3 receptor antagonist QCM-4 attenuates depressive-like phenotype associated with obesity in high-fat-diet-fed mice

Anxiolytic-like effects of alverine citrate in experimental mouse models of anxiety

Effect of a Selective Cyclooxygenase Type 2 Inhibitor Celecoxib on Depression Associated with Obesity in Mice: An Approach Using Behavioral Tests

Suchergebnisse filtern